| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
KREBS BIOCHEMICALS & INDUSTRIES LTD. (BSE: 524518)
524518 Technical Analysis
1.5
| As on 18th Apr 2024 524518 SHARE Price closed @ 71.94 and we RECOMMEND Sell for LONG-TERM with Stoploss of 72.36 & Buy for SHORT-TERM with Stoploss of 70.87 we also expect STOCK to react on Following IMPORTANT LEVELS. |
524518SHARE Price
| Open | 71.74 | Change | Price | % |
| High | 73.45 | 1 Day | 0.30 | 0.42 |
| Low | 71.73 | 1 Week | 1.41 | 2.00 |
| Close | 71.94 | 1 Month | 5.63 | 8.49 |
| Volume | 326 | 1 Year | -2.19 | -2.95 |
| 52 Week High 93.20 | 52 Week Low 59.30 | ||||
BSE INDIA Most Active Stocks
| 532822 | 13.20 | 2.17% |
| 532775 | 1.77 | 3.51% |
| 512149 | 1.05 | 3.96% |
| 532648 | 23.89 | -0.29% |
| 517001 | 0.09 | 12.50% |
| 504351 | 2.27 | 4.61% |
| 532407 | 132.51 | 19.99% |
| 532532 | 21.34 | 1.81% |
| 511389 | 7.25 | -2.42% |
| 534690 | 7.65 | 4.79% |
BSE INDIA Top Gainers Stocks
BSE INDIA Top Losers Stocks
| 524518 Daily Charts |
524518 Intraday Charts |
Whats New @ Bazaartrend |
524518 Free Analysis |
|
|
524518 Important Levels Intraday
| RESISTANCE | 75.25 |
| RESISTANCE | 74.19 |
| RESISTANCE | 73.53 |
| RESISTANCE | 72.88 |
| SUPPORT | 71.00 |
| SUPPORT | 70.35 |
| SUPPORT | 69.69 |
| SUPPORT | 68.63 |
524518 Target April 2024
| 4th UP Target | 88.92 |
| 3rd UP Target | 79.97 |
| 2nd UP Target | 74.44 |
| 1st UP Target | 68.91 |
| 1st DOWN Target | 53.13 |
| 2nd DOWN Target | 47.6 |
| 3rd DOWN Target | 42.07 |
| 4th DOWN Target | 33.12 |
524518 Weekly Target
| 4th UP Target | 77.24 |
| 3rd UP Target | 75.09 |
| 2nd UP Target | 73.76 |
| 1st UP Target | 72.43 |
| 1st DOWN Target | 68.63 |
| 2nd DOWN Target | 67.30 |
| 3rd DOWN Target | 65.97 |
| 4th DOWN Target | 63.82 |
524518 Target2024
| 4th UP Target | 209.95 |
| 3rd UP Target | 167.74 |
| 2nd UP Target | 141.65 |
| 1st UP Target | 115.56 |
| 1st DOWN Target | 41.12 |
| 2nd DOWN Target | 15.03 |
| 3rd DOWN Target | -11.06 |
| 4th DOWN Target | -53.27 |
KREBS BIOCHEMICALS & INDUSTRIES LTD. ( BSE INDIA Symbol : 524518 )
Sector : Other And Other Stocks in Same Sector
Sector : Other And Other Stocks in Same Sector
524518 Business Profile
Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry fields. Its products, such as androstenedione, lovastatin, and simvastatin for anti-cholesterol and steroid intermediate applications. The company is also developing various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. Krebs Biochemicals & Industries Limited was founded in 1991 and is headquartered in Hyderabad, India. Address: Maas Heights, Hyderabad, India, 500034
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service